EvodiaBio, a Denmark-based startup focused on biotechnological solutions, has raised €7m from prominent investment funds including The March Group and EIFO to advance its innovative agricultural technologies.

Target Information

EvodiaBio is a Denmark-based startup focused on developing innovative biotechnological solutions. The company aims to revolutionize the industry with its cutting-edge technologies that promise to enhance productivity and sustainability in agricultural practices.

Founded by a team of experienced professionals in the biotechnology sector, EvodiaBio has positioned itself as a key player in advanced bioengineering. Their research targets improving crop yields and resilience, which addresses critical challenges faced by the agricultural sector today.

Industry Overview

The biotechnology industry in Denmark has seen significant growth over the past few years, driven by increased investments in research and developme

View Source

Similar Deals

Korys Commit Biologics

2025

Seed Stage Biopharmaceuticals Denmark
Keystones Meat Tomorrow

2024

Seed Stage Biotechnology & Medical Research (NEC) Denmark
Keystones IMP Scandinavia

2024

Seed Stage Medical Monitoring Systems Denmark
DanBAN investors LifeBoard ApS

2023

Seed Stage Advanced Medical Equipment & Technology (NEC) Denmark
Danish Business Angels and Vækstfonden Knowledge Gate Group

2023

Seed Stage Biotechnology & Medical Research (NEC) Denmark
Novo Holdings Bactolife

2023

Seed Stage Biotechnology & Medical Research (NEC) Denmark

The March Group and EIFO

invested in

EvodiaBio

in 2023

in a Seed Stage deal

Disclosed details

Transaction Size: $7M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert